Introduction {#s1}
============

Macrophages are specialized ("professional") phagocytic cells that facilitate wide-ranging processes in diverse species. As well as their roles in host immunity and inflammation, macrophages are important in processes such as limb regeneration in salamanders (Godwin et al., [@B38]), stripe formation and blood vessel repair in zebrafish (Liu et al., [@B71]; Eom and Parichy, [@B30]), and synaptic pruning during brain development in the mouse (Paolicelli et al., [@B89]; Zhan et al., [@B124]).

Macrophages were first described in detail by Ilya Metchnikoff, who discovered their ability to engulf, digest, and destroy cellular components from living and dead microbial and host cells (Metchnikoff, [@B80]; Gordon, [@B41]). In 1924, the term "reticuloendothelial system" was coined to describe the system of phagocytic cells and their antecedents (based on the observation that phagocytes often form reticular networks around endothelia; Aschoff, [@B11]; Yona and Gordon, [@B123]). Subsequently, in 1969, prominent immunologists decided that the term "reticuloendothelial" was no longer adequate to describe this system; it was therefore relabeled as "the mononuclear phagocyte system" to reflect increased knowledge about the functions and morphology of monocytes, dendritic cells, and macrophages, and the derivation of these cells from the bone marrow (van Furth et al., [@B120]; Yona and Gordon, [@B123]). More recently, the notion that phagocytic cells derive chiefly from adult bone marrow-derived monocytes has been challenged, as evidence has accumulated showing that most adult tissue-resident macrophages derive from embryonic macrophages (Schulz et al., [@B105]; Hashimoto et al., [@B48]; Epelman et al., [@B31]; Hoeffel et al., [@B49]; Sheng et al., [@B107]).

The first data highlighting that macrophage precursors exist in the yolk sac and fetal liver of the early embryo were published over 40 years ago (Moore and Metcalf, [@B82]; Cline and Moore, [@B23]). We now have a detailed understanding of how these cells contribute to various adult tissue-resident macrophage populations, and there are many informative reviews on this subject (Epelman et al., [@B32]; Hoeffel and Ginhoux, [@B50]; Varol et al., [@B121]; Ginhoux et al., [@B37]). However, no reviews have focused specifically on describing the origins of kidney macrophages. Moreover, limited information is available about the functions of macrophages within the developing kidney. Here, we provide a comprehensive overview of the available data regarding the origins, specification, and functions of kidney macrophages in renal development. In this review, we also relate recent findings to emerging concepts in the field of macrophage research and highlight important questions that are still to be addressed.

Origins of tissue-resident macrophages {#s2}
======================================

During embryogenesis, macrophages colonize developing organs in overlapping waves (Schulz et al., [@B105]; Hoeffel et al., [@B49]; Sheng et al., [@B107]). Due to their remarkable capacity to self-renew *in situ*, many of these embryonic macrophages remain in adult tissues (Merad et al., [@B79]; Ajami et al., [@B4]; Hashimoto et al., [@B48]; Sieweke and Allen, [@B110]; Hoeffel et al., [@B49]). This fact contradicts the long-held belief that adult tissue-resident macrophages derive from, and are continually replenished by, circulating monocytes (van Furth and Cohn, [@B119]; van Furth et al., [@B120]). In this review, we describe tissue-resident macrophage origins in the mouse, as there is a paucity of information about their origins in the human.

The yolk sac provides the first wave of macrophages during development, commencing at embryonic day 7 (E7), before the embryonic circulation is established (Moore and Metcalf, [@B82]; Palis et al., [@B88]; McGrath et al., [@B77]). Erythro-myeloid progenitors (EMPs) emerge from the blood islands and capillary endothelia of the yolk sac (Kasaai et al., [@B56]). These cells form independently of c-Myb, a master transcriptional regulator of hematopoiesis (Sumner et al., [@B113]; Sandberg et al., [@B100]; Gomez Perdiguero and Geissmann, [@B39]). Rather than passing through an intermediate monocytic phase, c-Myb-independent EMPs directly acquire a core macrophage transcriptional programme and differentiate into pre-macrophages (pMacs) before maturing into tissue-resident macrophages (Takahashi et al., [@B114]; Schulz et al., [@B105]; Mass et al., [@B75]). At E8.5, when the yolk sac vasculature connects with the embryonic vasculature, these yolk sac macrophages migrate throughout the embryo and enter tissues such as the early brain and liver (Kierdorf et al., [@B61]; Gomez Perdiguero et al., [@B40]).

From mouse E8.5, a second set of EMPs, which are c-Myb-dependent, emerge from hemogenic endothelia in the yolk sac (Hoeffel et al., [@B49]). Many of these EMPs travel through the embryonic vasculature to colonize the fetal liver (McGrath et al., [@B76]; Mass et al., [@B75]). Due to their rapid expansion in the liver, by E11.5, the number of liver-EMPs exceeds the number of yolk sac-EMPs by 25-fold (Gomez Perdiguero et al., [@B40]). Concurrent with their expansion in the liver, the c-Myb-dependent EMPs differentiate into monocytic intermediates (Hoeffel et al., [@B49]) and/or into pMacs (Mass et al., [@B75]). To exit the fetal liver, pMacs/monocytes must pass through diaphragms in the fenestrae of liver sinusoidal endothelium (Rantakari et al., [@B95]). Once through the diaphragms, they travel through the vasculature to all embryonic tissues (except the brain, which is now isolated by the blood-brain barrier). These fetal liver-EMPs represent the second wave of macrophages during development.

Adding to the ontogenetic diversity, hematopoietic stem cells (HSCs) are generated by hemogenic endothelium, primarily in the dorsal aorta in the aorta-gonad-mesonephros region (Medvinsky and Dzierzak, [@B78]; Yokomizo and Dzierzak, [@B122]). Fetal HSCs represent a third developmental wave of macrophages contributing to tissue-resident macrophage pools (Sheng et al., [@B107]). They enter the fetal liver from E10.5, expand and differentiate into monocytic intermediates, and then colonize tissues and mature into tissue-resident macrophages (Kumaravelu et al., [@B63]; Kieusseian et al., [@B62]; Sheng et al., [@B107]). During embryogenesis, HSCs also populate the bone marrow and spleen, where they are maintained postnatally as progenitors that can generate a constant supply of monocytes that can be released into the circulation. These HSC-derived adult circulating monocytes contribute to tissue-resident macrophage pools during tissue homeostasis in specific organs, such as the heart and intestine (Bain et al., [@B13]; Epelman et al., [@B31]). In cases of injury and/or inflammation, an organ will recruit additional circulating monocytes that may worsen or limit the damage inflicted on the tissue (Tsou et al., [@B116]; Li et al., [@B67]; Shi and Pamer, [@B108]; Seok et al., [@B106]).

Recently, another bone marrow-derived source of adult macrophage progenitors has been discovered (Audzevich et al., [@B12]). These cells are bi-phenotypic early pro-B cells that express both myeloid and lymphoid markers. Like HSC-derived monocytes, early pro-B cells exit the bone marrow, travel through the circulation, and contribute to certain tissue-resident macrophage populations (such as in the peritoneum, pleural cavity, and intestine) during tissue homeostasis and inflammation (Audzevich et al., [@B12]).

Thus, in most adult organs, tissue-resident macrophages derive from (1) fetal-generated macrophages that self-renew *in situ* (descending from the waves of progenitors) and (2) the engraftment of adult circulating macrophage progenitors (Figure [1](#F1){ref-type="fig"}).

![Overlapping waves of macrophage progenitor cells colonize the developing embryo. Wave 1: Yolk sac-derived erythro-myeloid progenitors (EMPs) differentiate into pMacs and migrate through the early embryo. Wave 2: EMPs, derived from hemogenic endothelium in the yolk sac, enter the fetal liver. In the fetal liver, EMPs expand and differentiate into pMacs and/or monocytes. pMacs/monocytes then egress from the fetal liver and travel through the vasculature into developing organs. Wave 3: Haematopoietic stem cells (HSCs) from the aorta-gonad-mesonephros region also enter the fetal liver and contribute to resident macrophage populations. Some HSCs migrate into the bone marrow and the spleen where they are maintained before being released into the bloodstream postnatally as circulating monocytes that can contribute to tissue-resident macrophage populations. Early pro-B cells are also released from the bone marrow in adulthood and can contribute to certain tissue-resident macrophage populations. Depending on where they engraft, macrophage progenitors start to express transcriptional regulators that define their genetic programme in a tissue-specific manner. EMP, erythro-myeloid progenitor; HSC, haematopoietic stem cell; pMac, pre-macrophage; Camera lucida drawings adapted, with permission, from illustrations by Perry (Gordon et al., [@B42]).](fphys-08-00837-g0001){#F1}

Origins of kidney macrophages {#s3}
=============================

From the start of kidney development to the end of life, kidney-resident macrophages derive from all the progenitor waves described above: early yolk sac EMP-derived macrophages (Schulz et al., [@B105]; Hoeffel et al., [@B49]), fetal liver EMP-derived macrophages (Epelman et al., [@B31]; Hoeffel et al., [@B49]), HSC-derived macrophages (Epelman et al., [@B31]; Sheng et al., [@B107]), and adult bone marrow-derived circulating monocytes (Jang et al., [@B52]; de Cortie et al., [@B27]; Hoeffel et al., [@B49]; Sheng et al., [@B107]). The relative proportion of progenitors from each wave, however, changes dramatically throughout kidney development, adulthood, and in periods of disease.

The mouse metanephric (permanent) kidney begins to develop at \~E10.5, when the ureteric bud (the precursor of the collecting duct and ureter) emerges from the caudal end of the Wolffian/nephric duct in response to glial cell-line-derived neurotrophic factor (GDNF; Sainio et al., [@B99]). The ureteric bud invades the metanephric mesenchyme, a cell population comprised of nephron and stromal progenitors, and begins to branch. Throughout kidney development, signals from the metanephric mesenchyme induce further branching of the ureteric bud (Sainio et al., [@B99]; Majumdar et al., [@B72]; Costantini and Shakya, [@B25]). Simultaneously, ureteric bud branching induces nephron formation (Carroll et al., [@B19]) and guides vascular patterning (Munro et al., [@B84]).

There are no data regarding macrophage origins in the E10.5-E12 mouse kidney, possibly because so few macrophages are present in the kidney at this early developmental stage (Rae et al., [@B93]). At E12.5, however, flow cytometry analyses have revealed that kidney macrophages are yolk-sac EMP-derived (CD45^+^CD11b^lo^F4/80^hi^Ly6C^−^ cells). At this stage, no monocytes (CD45^+^CD11b^hi^F4/80^lo^Ly6C^+^ cells) are present within the kidney (Hoeffel et al., [@B49]). In fate-mapping studies with timed injections of hydroxytamoxifen (4′OHT) into tamoxifen-inducible *Runx1*^Cre/EYFP^ and *Csf1r*^Cre/EYFP^ mice (at E7.5 and E8.5, respectively; to label yolk sac macrophages and their progeny), the percentage of yolk sac-derived macrophages in the kidney was found to decrease exponentially from E13.5 to postnatal week 6 (Hoeffel et al., [@B49]). Runt-related transcription factor 1 (Runx1) is expressed by yolk sac-derived macrophage progenitors as they bud from hemogenic endothelium, and induction of labeling at E7.5 in *Runx1*^Cre/EYFP^ mice leads to specific EYFP-labeling of these cells (for details, see Hoeffel and Ginhoux, [@B50]). Colony stimulating factor 1 receptor (Csf1r) is expressed by all yolk sac-derived macrophage progenitors, and induction of labeling at E8.5 in *Csf1r*^Cre/EYFP^ mice leads to exclusive EYFP-labeling of these cells (for details, see Epelman et al., [@B32]; Hoeffel et al., [@B49]). These data agree with the findings of Epelman et al. ([@B31]), who used similar techniques (i.e., timed injections of 4′OHT into tamoxifen-inducible *Csf1r*^Cre/GFP^ mice at E8.5) to show that yolk sac-derived macrophages make a minimal contribution to the pool of kidney macrophages by postnatal week 10. As yolk sac-derived macrophages are highly proliferative (based on flow cytometry analysis of Fucci-reporter embryos), and do not exhibit high rates of apoptosis (based on Annexin-V labeling followed by flow cytometry analysis), it has been speculated that this rapid decrease in the proportion of yolk sac-derived macrophages must be explained by their dilution by the marked later arrival of fetal monocytes (Hoeffel et al., [@B49]; Figure [2](#F2){ref-type="fig"}).

![Contribution of yolk sac-derived and monocyte-derived macrophages to the embryonic and postnatal kidney. The trends shown in the yolk sac-derived and monocyte-derived macrophage graphs are based on fate-mapping experiments by Hoeffel et al. ([@B49]). Trends for the origins of brain macrophages (microglia), which are yolk sac-derived, are shown as a comparison. Adapted with permission from Hoeffel et al. ([@B49]).](fphys-08-00837-g0002){#F2}

Fetal monocytes begin to populate the mouse kidney by E13.5 (Epelman et al., [@B31]; Hoeffel et al., [@B49]). Between E13.5 and E16.5, the proportion of monocyte-derived macrophages within the kidney progressively increases, and rapidly exceeds that of yolk sac-derived macrophages (Epelman et al., [@B31]; Hoeffel et al., [@B49]). Indeed, multiple studies have shown that adult kidney macrophages are almost exclusively fetal monocyte-derived (Epelman et al., [@B31]; Hoeffel et al., [@B49]; Sheng et al., [@B107]); however, it is not clear whether these monocytes are generated from EMPs, HSCs, or a combination of both sources.

The precise origins of monocyte-derived kidney macrophages have been explored using various fate-mapping mouse models. In support of a HSC-derived source of adult kidney macrophages, Sheng et al. ([@B107]) generated a tamoxifen-inducible c-Kit^Cre/EYFP^ mouse strain to fate-map the progeny of HSCs (all HSCs express c-Kit and induction of labeling leads to specific EYFP-labeling of these cells; for details, see Sheng et al., [@B107]); by labeling cells at several time-points they concluded that adult kidney macrophages derive from the HSC-precursor wave, rather than from EMPs. However, as c-Kit is expressed by EMPs as well as HSCs (Gomez Perdiguero et al., [@B40]), it is unclear whether this mouse model can reliably distinguish HSC-progenitors from EMP-progenitors (Hoeffel and Ginhoux, [@B50]). In another study by Epelman et al. ([@B31]), fate-mapping experiments were performed using Flt3^Cre/GFP^ mice. Flt3 is expressed transiently by all HSCs (Boyer et al., [@B15]), so an assumption of this model is that any monocyte/macrophage that goes through a Flt3^+^ stage (Flt3^Cre/GFP+^) can be classed as HSC-derived, whereas those that do not go through a Flt3^+^ stage (Flt3^Cre/GFP−^) can be said to be HSC-independent. Epelman et al. ([@B31]) demonstrated that recombination rates driven by Flt3 in adult kidney macrophages were \~50%, suggesting that there is a large contribution from both HSC-derived monocytes and HSC-independent, EMP-derived, monocytes to the pool of kidney-resident macrophages (Epelman et al., [@B31]). Lastly, Hoeffel et al. ([@B49]) determined that adult kidney macrophages predominantly arise from late c-Myb^+^ EMP-derived fetal monocytes. After injecting 4′OHT at E8.5 in the tamoxifen-inducible *Runx1*^Cre/EYFP^ fate-mapping mouse model, EMPs and their progeny were efficiently labeled, while there was only minor labeling of HSCs. Many of the labeled EMPs reached the fetal liver, and a significant proportion of these cells converted into the monocytes and macrophages that ultimately colonize various developing organs such as the kidney (Hoeffel et al., [@B49]). Together, these studies suggest that both EMP- and HSC-derived monocytes enter the kidney to generate mature kidney macrophages. However, the relative contribution of each progenitor type remains unclear. To explain the incongruent conclusions presented by these studies, further analyses of the specific drawbacks and limitations of the various fate-mapping models are necessary (as reviewed by Hoeffel and Ginhoux, [@B50]).

In adulthood, bone marrow-derived circulating monocytes colonize the healthy kidney at low levels (Sheng et al., [@B107]). When the kidney becomes diseased/inflamed/injured, monocyte infiltration dramatically increases, as has been shown in multiple experiments where the engraftment of bone-marrow derived cells was assessed in irradiated mice (Jang et al., [@B52]; de Cortie et al., [@B27]; Hoeffel et al., [@B49]).

In summary, kidney macrophage origins are diverse: the early kidney is colonized by yolk sac-derived macrophages, but the resident macrophages in the early postnatal kidney are predominantly derived from EMP- and HSC-derived monocytic precursors (Figure [2](#F2){ref-type="fig"}). These fetal-generated macrophages self-maintain throughout adulthood and are only partially replaced by bone marrow-derived circulating monocytes.

What dictates kidney macrophage origins? {#s4}
========================================

Although macrophage origins clearly differ between organs (Schulz et al., [@B105]; Hashimoto et al., [@B48]; Epelman et al., [@B31]; Hoeffel et al., [@B49]), the origin of a tissue-resident macrophage does not seem to play a large role in determining its lifespan or functions (van de Laar et al., [@B118]; Guilliams and Scott, [@B45]). This begs the question, "why do macrophage origins differ?"

A recent hypothesis proposed to explain the differences in macrophage origins between tissues is the niche competition model, as proposed by Guilliams and Scott ([@B45]). In this model, macrophage precursors populate a niche depending on its *accessibility*, its *availability*, and macrophage *precursor plasticity*. As macrophage precursors are extremely plastic (van de Laar et al., [@B118]; Guilliams and Scott, [@B45]), the question about macrophage ontogeny comes down to niche *accessibility* (e.g., can macrophage precursors access the organ via the circulation?) and *availability* (e.g., are there unoccupied niches in this organ for macrophage progenitors to exploit?).

Because the kidney is *accessible* to macrophage precursors via the systemic circulation throughout most of embryonic development (from \~E11.5; Munro et al., [@B84]) and adult life, it is unsurprising that kidney-resident macrophages derive from multiple waves of progenitors (Schulz et al., [@B105]; Ginhoux et al., [@B37]). In contrast, other organs, most notably the brain, become inaccessible to blood-borne cells during development: macrophage entry into the brain becomes restricted due to the establishment of the blood-brain-barrier and, consequently, brain macrophages (microglia) derive solely from the early yolk sac macrophages (Alliot et al., [@B7]; Hoeffel et al., [@B49]; Figure [2](#F2){ref-type="fig"}).

As the kidney enlarges developmentally, its capacity for macrophage niches, and therefore its *availability* to house macrophages, will increase (Figure [3](#F3){ref-type="fig"}). Consequently, macrophages will colonize and fill these "developmental macrophage niches" as the kidney matures (from E10.5-P4; Short and Smyth, [@B109]). As kidney development ends, macrophage niches become fully occupied and, as a result, the macrophages that become resident within the kidney are predominantly embryonically/neonatally-derived (Epelman et al., [@B31]; Hoeffel et al., [@B49]; Sheng et al., [@B107]). As these macrophages are long-lived and self-renew *in situ*, few circulating monocytes are provided with the opportunity to engraft within the kidney in adulthood (Figure [3](#F3){ref-type="fig"}). An exception to this might be during renal disease/inflammation/injury when niches become temporarily available due to the drainage of macrophages from the kidney via the lymphatics (Lan et al., [@B64]) and surges of macrophage-recruiting chemokines (Petrovic-Djergovic et al., [@B91]; Figure [3](#F3){ref-type="fig"}).

![Multiple origins of kidney macrophages. Murine kidneys contain macrophages that are derived from multiple sources, with their relative proportions fluctuating throughout development and adulthood. Based on the niche competition hypothesis of macrophage origins (Guilliams and Scott, [@B45]), we argue that the mixed ontogeny of kidney macrophages is the result of kidney niches being both *accessible* and *available* to macrophage precursors throughout kidney development and phases of adulthood. The "**?**" in some of the yellow bone marrow-derived monocytes denotes that we do not know whether these cells are maintained in the kidney after the resolution of inflammation/disease. The increasing volumes of the cups represent the increasing capacity of the kidney to house macrophages.](fphys-08-00837-g0003){#F3}

As well as being *accessible* and *available* to macrophages, an organ must produce signals to recruit macrophages. Signaling through Cx3c chemokine receptor 1 (Cx3cr1), the receptor for chemokine Cx3c motif ligand 1 (Cx3cl1), is important for macrophage migration and colonization of the early embryo (Imai et al., [@B51]; Mass et al., [@B75]). Caudal tissues, limbs, and the head of *Cx3cr1*-deficient embryos have decreased numbers of macrophages at E9.5 and E10.5 (Mass et al., [@B75]). However, most organs (lung, liver, and brain) in *Cx3cr1*^−/−^ embryos have normal macrophage numbers by E14.5 and in adulthood (relative to *Cx3cr1*^+/−^ littermates). Conversely, kidneys of *Cx3cr1*^−/−^ embryos have greatly diminished macrophage numbers at E14.5 and in adulthood (relative to *Cx3cr1*^+/−^ littermates; Mass et al., [@B75]). In agreement, Lionakis et al. ([@B69]) also found that adult kidneys of *Cx3cr1*^−/−^ mice have reduced macrophage numbers. Moreover, kidneys of *Cx3cr1*^−/−^ mice recruited fewer macrophages in response to systemic infection with the fungus *Candida albicans* (relative to *Cx3cr1*^+/+^ mice). In *Cx3cr1*-deficient mice, this fungus was cleared from all organs tested apart from the kidney. Consequently, *Cx3cr1*^−/−^ mice uniformly succumbed to infection due to uncontrolled fungal proliferation in the kidney and renal failure (Lionakis et al., [@B69]). These data indicate that the Cx3cl1/Cx3cr1 signaling pathway is uniquely important for the recruitment of macrophages to the kidney during development, at steady state, and in response to infection.

Specification of kidney macrophages {#s5}
===================================

The expression of transcriptional regulators in a tissue-resident macrophage is regulated in a tissue-specific manner (Lavin et al., [@B65]; Amit et al., [@B8]; Mass et al., [@B75]). This regulation results in macrophages being specialized according to the needs of their specific organ of residence. Bulk RNA-seq data have identified candidate transcriptional regulators that might act to control kidney macrophage programming and differentiation (Mass et al., [@B75]).

In comparison to those in other developing organs (i.e., brain, liver, skin, and lung), kidney macrophages exhibit increased expression of the transcriptional regulators aryl hydrocarbon receptor (Ahr), nuclear factor of activated T cells 1 and 2 (Nfatc1 and Nfatc2), and interferon regulatory factor 9 (Irf9) (Mass et al., [@B75]). Ahr influences macrophage activation and production of nitric oxide and arginine (Climaco-Arvizu et al., [@B22]). Irf9 also influences macrophage activation (Ganta et al., [@B36]). Nfatc1 and Nfatc2 are involved in macrophage cytokine expression and the inflammatory response (Minematsu et al., [@B81]; Elloumi et al., [@B29]). However, although more highly expressed in kidney-resident than other resident macrophages, the effects of these transcriptional regulators on kidney macrophage specification and function have not been investigated.

A complication regarding the study of macrophage specification is the heterogeneity of macrophages, even within a single organ. In the adult kidney, there are at least five types of tissue-resident macrophages (Kawakami et al., [@B57]). Based on the multidimensional model of macrophage activation, macrophage specification depends on the integration of the environmental signals to which it is exposed, rather than being based on macrophage ontogeny (Ginhoux et al., [@B37]). The chemokine environment within the kidney will not be spatially uniform, and the micro-anatomical site of a macrophage will dictate its specification. For example, a macrophage is not exposed to identical signals in the renal cortex and the renal medulla (Berry et al., [@B14]). Furthermore, exogenous stress signals, such as small immune complexes (Stamatiades et al., [@B111]) that are carried into the kidney via the blood will also control macrophage specification in an environment-specific manner (Figure [4](#F4){ref-type="fig"}). Future studies should investigate how the integration of endogenous and exogenous signals dictates the phenotypes and functions of kidney macrophages in development and adulthood.

![Kidney macrophage specification. During development, the tissue-specific signals that kidney macrophages are exposed to provoke the expression of a unique array of transcriptional regulators. Compared to other tissue-resident macrophages, kidney macrophages have increased expression of transcriptional regulators such as Nfatc1, Nfatc2, Ahr, and Irf9. In adulthood, macrophages are exposed to various exogenous stress signals because of factors such as disease, diet, and infection. Based on the multidimensional model of macrophage activation, a macrophage is specified by the integrated effects of the endogenous and exogenous signals within its micro-anatomical site. The macrophage colors are used to show the heterogeneity of macrophage activation status in response to endogenous and exogenous signals in the kidney. DAMPS, damage-associated molecular pattern molecules; PAMPS, pathogen-associated molecular pattern molecules.](fphys-08-00837-g0004){#F4}

Functions of macrophages in kidney development {#s6}
==============================================

While numerous reviews have detailed the functions of kidney macrophages in the healthy and diseased adult kidney (Rogers et al., [@B97]; Cao et al., [@B18]; Guiteras et al., [@B46]), there are few descriptions of the functions of kidney macrophages in renal development. In other developing organs, macrophages are critical in processes such as branching morphogenesis, angiogenesis, and the clearance of dead cells (Gouon-Evans et al., [@B43]; Kawane et al., [@B58]; Pollard, [@B92]; DeFalco et al., [@B28]; Sathi et al., [@B101]). It is now becoming clear that these processes are also facilitated by kidney macrophages during renal organogenesis.

Cell death and clearance {#s7}
========================

An appropriate balance between cell death, survival, and proliferation is crucial for organ growth and remodeling during development (Penaloza et al., [@B90]). Cell death in the developing kidney peaks at E14.5 (0.25% of cells are apoptotic) and then drops considerably after birth (by postnatal day 14, only 0.06% of cells are apoptotic; Foley and Bard, [@B35]). Apoptosis during kidney development may facilitate the reciprocal signaling between the ureteric bud and nephron progenitor cells (Coles et al., [@B24]; Foley and Bard, [@B35]; Stewart and Bouchard, [@B112]). Inhibition of apoptosis in kidney explants, via blockade of caspase −3 and −9, reduces branching morphogenesis and nephrogenesis (Araki et al., [@B10], [@B9]). The cellular debris released from these apoptotic cells is cleared via a process termed efferocytosis (Latin for "to take to the grave" or "to bury").

During renal development, efferocytosis is carried out by kidney macrophages (Camp and Martin, [@B17]; Erdösová et al., [@B33]). "Find me" chemokine signals and "eat me" cell surface signals that are expressed by dying cells attract macrophages to phagocytose them (Truman et al., [@B115]; Nagata et al., [@B87]), resulting in the degradation of their cellular components (A-Gonzalez and Hidalgo, [@B3]). Where efferocytosis is defective, the innate immune system becomes activated, which leads to inflammation (Green et al., [@B44]). This can have negative consequences on a developing organ; indeed, in the developing thymus, it impairs thymic organogenesis, reducing thymocyte number, and thymus size (Kawane et al., [@B58]). However, the consequences of impaired efferocytosis in the developing kidney have not been investigated.

Ureteric bud branching morphogenesis {#s8}
====================================

Macrophages contribute to branching morphogenesis in the developing lung, mammary gland, and submandibular gland (Gouon-Evans et al., [@B43]; Pollard, [@B92]; Jones et al., [@B53]; Sathi et al., [@B101]). Evidence suggests that kidney macrophages similarly contribute to ureteric bud branching in the kidney (Rae et al., [@B93]; Muthukrishnan et al., [@B86]).

The addition of colony stimulating factor-1 (Csf-1) accelerates growth and ureteric bud branching in cultured kidney explants (Rae et al., [@B93]). Binding of the Csf-1 ligand to its membrane receptor, Csf1r, results in the activation of the Csf1r pathway and the stimulation of macrophage proliferation, survival, and differentiation (Dai et al., [@B26]; Mouchemore and Pixley, [@B83]). Macrophage numbers were increased in the Csf-1 treated kidney explants and their expression profile was consistent with them being alternatively activated, pro-proliferative M2 macrophages (Rae et al., [@B93]). Although the M1/M2 model of macrophage activation is imperfect (Murray et al., [@B85]), an M2-like activation status is associated with trophic/tissue remodeling macrophages (Mantovani et al., [@B73]; Marchetti et al., [@B74]). However, Rae et al. ([@B93]) did not establish whether the trophic effects on kidney growth and ureteric bud branching were the result of the increased macrophage numbers, the alternative activation status of the macrophages, the exogenous addition of Csf-1 *per se*, or a combination of these possibilities. In support of the proposed trophic role of Csf-1 on kidney development, *in vivo* treatment of neonatal mice with Csf-1 resulted in the development of larger, heavier kidneys (Alikhan et al., [@B5]); as with the kidney explants, this growth was associated with increased numbers of tissue macrophages. Correspondingly, *Csf1r*-null mice have lighter kidneys compared to wild type mice (Alikhan et al., [@B5]) and male mice injected with an anti-Csf1r blocking antibody 3× weekly for 6 weeks have decreased kidney:body weight ratios (Sauter et al., [@B102]).

Kidney macrophages may also directly stimulate ureteric bud branching during development. Populations of nephron progenitor cells that cap ureteric bud tips (Reinhoff, [@B96]) secrete glial cell line-derived neurotrophic factor (Gdnf) to promote branching morphogenesis via activation of Ret receptor tyrosine kinase (Ret) on the membrane of ureteric bud epithelia (Schuchardt et al., [@B104]; Sainio et al., [@B99]). Following experimental ablation of nephron progenitor cells, macrophages compensate for their loss by localizing around ureteric bud tips and secreting Gdnf to maintain ureteric bud branching (Muthukrishnan et al., [@B86]). Whether macrophages play a similar role to directly stimulate ureteric bud branching during normal kidney development is currently unknown.

Nephron formation {#s9}
=================

In the developing kidney, many macrophages are found near renal tubules (Rae et al., [@B93]). A direct role of macrophages in facilitating nephron formation has not been described during normal renal organogenesis, but, as with ureteric bud branching, Csf-1 treated kidney explants developed greater numbers of nephrons (Rae et al., [@B93]). Furthermore, macrophages are recruited to the nephrogenic zone (the site of nephron formation) when nephron progenitor cells are experimentally ablated where they stimulate nephron progenitor proliferation (Muthukrishnan et al., [@B86]). However, the relevance of this experimental model to normal kidney development is unknown.

As nephron formation is unique to the kidneys (pronephros, mesonephros, and metanephros), it is difficult to relate macrophage functions in other developing mammalian organs with the creation of new nephrons. Here, some invertebrate species, such as the fruit fly (*Drosophila melanogaster*), are providing insights. In *D. melanogaster*, the Malpighian tubules perform the function of the kidney and hemocytes are analogous to macrophages. Hemocytes deposit type IV collagen around the developing renal tubules, which sensitizes tubular cells to the BMP ligand, Decapentaplegic (Dpp; Bunt et al., [@B16]). Without hemocytes, or collagen IV, failure of BMP signaling leads to the misrouting of the anterior Malpighian tubules (Bunt et al., [@B16]). Whether this process is conserved in the mammalian kidney has not been investigated, but the nephron tubular basement membrane is rich in collagen IV (Abrahamson and Leardkamolkarn, [@B2]) and both human and murine macrophages can facilitate the deposition of almost every type of collagen (Vaage and Lindblad, [@B117]; Schnoor et al., [@B103]).

Blood and lymphatic vessel development {#s10}
======================================

Macrophages facilitate the vascularization of many developing organs (Fantin et al., [@B34]; Rymo et al., [@B98]; DeFalco et al., [@B28]). In the developing kidney, many macrophages localize around blood and lymphatic vessels (Rae et al., [@B93]; Lee et al., [@B66]), but their interactions have not been examined.

In angiogenesis, functional blood vessels form through a two-step process: endothelial tip cells first sprout from pre-existing vessels and then secondly, fuse with other blood vessels (anastomosis). Macrophages facilitate endothelial anastomosis in development (Fantin et al., [@B34]) and in response to vascular rupture (Liu et al., [@B71]). They do this by directly adhering to endothelia before generating mechanical traction forces to pull vessels together (Liu et al., [@B71]).

Moreover, macrophages are sensitive to low oxygen levels, and can promote angiogenesis in response to hypoxia (Cattin et al., [@B20]). When oxygen levels are low, signaling via the p110γ isoform of phosphoinositide 3-kinase (PI3K), which is predominantly expressed in macrophages, stabilizes hypoxia-inducible transcription factor 1/2-alpha (HIF1α and HIF2α; Joshi et al., [@B54]). This results in HIF1/2α translocation to the macrophage nucleus, where it binds to hypoxia-responsive elements to induce the expression of pro-angiogenic genes such as VEGF (Joshi et al., [@B54]). Macrophage-derived VEGF-A stimulates angiogenesis by promoting endothelial proliferation and migration to resolve hypoxia (Cattin et al., [@B20]). Hypoxia plays a role in developmental angiogenesis in the kidney (Abrahamson, [@B1]), and future studies should investigate whether kidney macrophages respond to hypoxia by guiding angiogenesis.

A subset of macrophages in the developing kidney express lymphatic vessel endothelial hyaluronan receptor 1 (Lyve-1; Lee et al., [@B66]). Lyve-1 is an endocytic receptor for hyaluronan that is also highly expressed by lymphatic endothelia. Lyve-1^+^ macrophages are reportedly pro-angiogenic and pro-lymphangiogenic (Cho et al., [@B21]; Harvey and Gordon, [@B47]). Lee et al. ([@B66]) demonstrated that Lyve-1^+^ lymphatic endothelia are closely associated with Lyve-1^+^ macrophages in the developing kidney, and they speculated that the latter facilitate lymphatic development during renal organogenesis. This idea is supported by evidence that macrophages can express VEGF-C to stimulate lymphangiogenesis (Kerjaschki, [@B59]; Alishekevitz et al., [@B6]) and that macrophages can act as lymphatic endothelial progenitors that integrate into sprouting lymphatic vessels (Ran and Montgomery, [@B94]). Furthermore, a subtype of VEGF-C-expressing interstitial macrophages has previously been associated with lymphangiogenesis in human kidney transplants (Kerjaschki et al., [@B60]). Based on these data, kidney macrophages could play a role in stimulating lymphatic development in a VEGF-C dependent and/or independent manner.

Although it seems likely that kidney macrophages will facilitate the processes described above, more studies are undoubtedly required before we fully appreciate the functional requirements of macrophages during renal development (Figure [5](#F5){ref-type="fig"}).

![Functions of macrophages in kidney development. Processes including branching morphogenesis, cell proliferation/death (and clearance of cellular debris), nephron formation, and vascular development (blood and lymphatic) are important in renal development. Few studies have directly investigated the roles of kidney macrophages in these processes; however, based on available evidence, it is likely that macrophages will facilitate most, if not all, of these processes. Black stars indicate the strength of evidence that macrophages function in each process in kidney development (0 stars, no direct evidence; 5 stars, very strong evidence).](fphys-08-00837-g0005){#F5}

Conclusions and future directions {#s11}
=================================

In many organs, including the kidney, tissue-resident macrophages are predominantly derived from embryonic macrophages. In the kidney, these embryonic macrophages are mainly generated from fetal monocytes, which are specified and self-renew *in situ* throughout development and adulthood. Kidney macrophages are endowed with a unique genetic programme that allows them to promote normal renal organogenesis and to maintain the health and function of the adult organ. It will be extremely challenging to fully characterize the factors involved in kidney macrophage specification, and to understand how this dictates the functions of a given macrophage. Nevertheless, this is a challenge that should be faced, as it may expose new therapeutic opportunities to prevent and treat a range of developmental and pathological conditions.

To better understand kidney macrophage specification, future studies should utilize single-cell transcriptomic technologies to spatiotemporally classify the phenotypes of distinct macrophage populations in the developing kidney. By identifying clusters of macrophages with distinct gene expression patterns, and determining where they localize in the kidney, it may be possible to link environment-specific signals to the phenotypes and functions of a macrophage.

As macrophages can promote kidney growth, they could potentially be used therapeutically to assist renal development in babies at risk of preterm birth. Increasing macrophage recruitment to the developing kidney through treatment with chemokines such as Csf-1 and/or Cx3cr1 could conceivably promote kidney growth and nephron endowment. However, macrophages can also promote abnormalities in kidney development, such as cyst formation (Karihaloo et al., [@B55]), and their recruitment has previously been associated with disease progression in Wilms tumor (Liou et al., [@B70]); in these cases, the elimination of macrophages may be more therapeutic. Accordingly, macrophage-based therapies for developmental abnormalities will have to be context-dependent and will necessitate an in-depth understanding of kidney macrophage specification and function.

The inflammatory properties of kidney macrophages and recruited circulating monocytes are implicated in the initiation and progression of injury and scarring in the adult kidney as well as kidney regeneration and healing (reviewed in Rogers et al., [@B97]). Although beyond the scope of this review, it is of interest that the recruited monocyte-derived macrophages, but not kidney-resident macrophages, are pro-fibrotic in the obstructed kidney (Lin et al., [@B68]). In addition, commonalities exist between macrophages in the healing adult kidneys and the developing kidney (Alikhan et al., [@B5]). As well as the therapeutic potential of using macrophages to mitigate abnormal kidney development, studying the specification, and function of kidney macrophages in development may also provide new therapeutic/preventative options to minimize renal complications in adulthood.
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